Osteoporosis drugs on every 2026 Tennessee Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 12 stand-alone Part D plans in Tennessee cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
12 plans, cheapest premium first. Scroll sideways for all of them →
| Drug | Humana Basic Rx Plan$0.00/moS5884-106 | Wellcare Value Script$3.60/moS4802-147 | Wellcare Classic$3.70/moS4802-071 | Humana Value Rx Plan$37.70/moS5884-191 | AARP Medicare Rx Saver from UHC$63.20/moS5921-357 | BlueRx Essential$76.20/moS1030-006 | HealthSpring Extra Rx$77.50/moS5617-362 | HealthSpring Assurance Rx$87.20/moS5617-220 | SilverScript Choice$97.30/moS5601-024 | Humana Premier Rx Plan$108.60/moS5884-158 | AARP Medicare Rx Preferred from UHC$119.30/moS5921-393 | BlueRx Enhanced Plus$129.50/moS1030-001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| alendronategeneric Fosamax | Tier 2$1.00QL 30/30d | Tier 1$0.00QL 30/30d | Tier 1$0.00QL 30/30d | Tier 1$0.00QL 30/30d | Tier 2$8.00QL 30/30d | Tier 1$2.00QL 120/30d | Tier 1$0.00 | Tier 1$0.00QL 30/30d | Tier 1$0.00 | Tier 1$0.00QL 30/30d | Tier 1$5.00QL 30/30d | Tier 1$0.00QL 120/30d |
| risedronategeneric Actonel | Not covered | Tier 2$3.00QL 1/30d | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Tier 433%QL 1/28d | Not covered | Not covered | Tier 2$12.00QL 1/28d |
| ibandronategeneric Boniva | Tier 325%QL 1/28d | Tier 2$3.00QL 1/30d | Tier 325%QL 1/30d | Tier 320%QL 1/28d | Tier 317%QL 1/28d | Tier 2$10.00QL 1/28d | Tier 317%QL 1/28d | Tier 322%QL 1/28d | Tier 433%QL 1/30d | Tier 3$45.00QL 1/28d | Tier 317%QL 1/28d | Tier 2$12.00QL 1/28d |
| Proliadenosumab | Tier 434%QL 1/180d | Not covered | Not covered | Tier 433%QL 1/180d | Not covered | Not covered | Tier 431%QL 1/180d | Tier 432%QL 1/180d | Not covered | Tier 450%QL 1/180d | Not covered | Not covered |
| denosumab biosimilarsJubbonti, Ospomyv and others | Not covered | Tier 440%QL 1/180d | Tier 427%QL 1/180d | Not covered | Tier 435%QL 1/180d | Tier 4PA41% | Not covered | Not covered | Tier 433%QL 1/180d | Not covered | Tier 434%QL 1/180d | Tier 4PA42% |
| Evenityromosozumab | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| Forteoteriparatide | Tier 5PA25%QL 2.24/28d | Not covered | Not covered | Tier 5PA26%QL 2.24/28d | Not covered | Not covered | Not covered | Not covered | Not covered | Tier 5PA33%QL 2.24/28d | Not covered | Not covered |
| teriparatidegeneric Forteo | Not covered | Tier 5PA25%QL 2.48/28d | Tier 5PA25%QL 2.48/28d | Not covered | Tier 5PA25%QL 2.48/28d | Not covered | Tier 5PA25%QL 2.48/28d | Tier 5PA25%QL 2.48/28d | Tier 5PA25% | Not covered | Tier 5PA31%QL 2.48/28d | Tier 5PA31% |
| Tymlosabaloparatide | Not covered | Not covered | Not covered | Not covered | Not covered | Tier 5PA25% | Not covered | Not covered | Tier 5PA25% | Not covered | Tier 5PA31%QL 1.56/30d | Tier 5PA31% |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.